KOR

e-Article

Brain pharmacokinetics and metabolism of the AMP-activated protein kinase selective inhibitor SBI-0206965, an investigational agent for the treatment of glioblastoma.
Document Type
Article
Source
Investigational New Drugs; Oct2022, Vol. 40 Issue 5, p944-952, 9p
Subject
BRAIN metabolism
KETOCONAZOLE
IN vitro studies
ANIMAL experimentation
BIOAVAILABILITY
GLIOMAS
TREATMENT effectiveness
MOLECULAR structure
ADENOSINE monophosphate
MICE
Language
ISSN
01676997
Abstract
Copyright of Investigational New Drugs is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)